Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Finance
Theragenics reports consolidated revenue for Q4 2006 of $14.8 million, up 30% over year ago
February 27th, 2007
Theragenics Corporation (TGX), a medical device company serving the cancer treatment and surgical products markets, announced consolidated revenue for the fourth quarter ended December 31, 2006, of $14.8 million, an increase of $3.4 million, or 30% over the fourth quarter of 2005. For the 12-month period ended December 31,2006, consolidated revenue was $54.1 million, an increase of $9.8 million, or 22%, compared to the prior year. Net income for the quarter was $3.7 million or 11 cents per share, compared to a net loss of $236,000, or minus 1 cent per share in the fourth quarter of 2005. For the year, net income was $6.6 million, or 20 cents per share, compared to a net...
Source: Cancer Weekly (2007-02-27)
|
